IBOV 172,236.05 ▲ 2.22% IPC MEX 71,866.30 ▲ 0.66% MERVAL 2,848,945 — — USD/BRL5.51▲ 0.05% USD/MXN18.46▼ 0.37% USD/CLP966.96▼ 0.99% USD/COP3,267▲ 4.70% USD/PEN3.41▼ 1.07% USD/ARS1,545▼ 0.02% USD/UYU40.45▲ 0.35% USD/PYG6,450▲ 1.45% USD/BOB11.74▼ 0.59% USD/DOP60.46▲ 2.41% USD/CRC446.56▼ 0.38% USD/GTQ7.64▼ 0.05% USD/HNL26.89▲ 0.02% USD/NIO36.62▲ 2.53% USD/VES897.02▲ 0.07% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.79▲ 2.42% USD/TTD6.72▼ 0.03% EUR/BRL6.19▲ 0.99% BRENT 90.63 ▼ 2.10% WTI 85.11 ▼ 2.00% IRON ORE 161.91 — — COPPER 6.33 ▼ 0.01% GOLD 4,101 ▼ 0.32% SILVER 52.55 ▼ 0.03% SOY 1,196 ▲ 1.14% CORN 441.75 ▲ 0.57% WHEAT 591.25 ▲ 0.55% COFFEE 273.45 ▼ 0.05% SUGAR 18.12 ▼ 0.49% ORANGE JUICE 143.50 ▲ 7.85% COTTON 82.72 ▲ 5.00% COCOA 5,000 ▼ 3.01% BEEF 216.33 ▲ 1.06% CATTLE 328.83 ▲ 2.02% LITHIUM 61.35 ▲ 0.72% PETR4 45.19 ▼ 0.24% VALE3 66.11 ▲ 3.23% ITUB4 41.72 ▲ 2.94% BBDC4 14.68 ▲ 3.38% ABEV3 15.61 ▲ 0.84% BBAS3 17.02 ▼ 0.64% B3SA3 14.85 ▲ 3.20% WEGE3 50.74 ▲ 5.29% PRIO3 59.39 ▼ 1.80% SUZB3 54.20 ▲ 1.50% RENT3 30.83 ▲ 1.78% AZZA3 15.12 ▲ 2.44% CSAN3 2.77 — 0.00% RAIZ4 24.40 ▼ 12.86% PCAR3 2.43 ▲ 1.25% GMAT3 3.83 ▲ 0.79% PSSA3 45.65 ▲ 2.93% CVCB3 0.87 ▲ 3.57% POSI3 3.03 ▼ 1.94% SLCE3 17.30 ▲ 4.15% NATU3 5.71 ▲ 10.44% BRKM5 3.02 ▼ 5.63% RANI3 8.76 ▲ 3.44% CSNA3 4.49 ▲ 1.81% IBOV 172,236.05 ▲ 2.22% IPC MEX 71,866.30 ▲ 0.66% MERVAL 2,848,945 — — USD/BRL 5.51 ▲ 0.05% USD/MXN 18.46 ▼ 0.37% USD/CLP 966.96 ▼ 0.99% USD/COP 3,267 ▲ 4.70% USD/PEN 3.41 ▼ 1.07% USD/ARS 1,545 ▼ 0.02% USD/UYU 40.45 ▲ 0.35% USD/PYG 6,450 ▲ 1.45% USD/BOB 11.74 ▼ 0.59% USD/DOP 60.46 ▲ 2.41% USD/CRC 446.56 ▼ 0.38% USD/GTQ 7.64 ▼ 0.05% USD/HNL 26.89 ▲ 0.02% USD/NIO 36.62 ▲ 2.53% USD/VES 897.02 ▲ 0.07% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.79 ▲ 2.42% USD/TTD 6.72 ▲ 2.10% EUR/BRL 6.19 ▲ 0.99% BRENT 90.63 ▼ 2.10% WTI 85.11 ▼ 2.00% IRON ORE 161.91 — — COPPER 6.33 ▼ 0.01% GOLD 4,101 ▼ 0.32% SILVER 52.55 ▼ 0.03% SOY 1,196 ▲ 1.14% CORN 441.75 ▲ 0.57% WHEAT 591.25 ▲ 0.55% COFFEE 273.45 ▼ 0.05% SUGAR 18.12 ▼ 0.49% ORANGE JUICE 143.50 ▲ 7.85% COTTON 82.72 ▲ 5.00% COCOA 5,000 ▼ 3.01% BEEF 216.33 ▲ 1.06% CATTLE 328.83 ▲ 2.02% LITHIUM 61.35 ▲ 0.72% PETR4 45.19 ▼ 0.24% VALE3 66.11 ▲ 3.23% ITUB4 41.72 ▲ 2.94% BBDC4 14.68 ▲ 3.38% ABEV3 15.61 ▲ 0.84% BBAS3 17.02 ▼ 0.64% B3SA3 14.85 ▲ 3.20% WEGE3 50.74 ▲ 5.29% PRIO3 59.39 ▼ 1.80% SUZB3 54.20 ▲ 1.50% RENT3 30.83 ▲ 1.78% AZZA3 15.12 ▲ 2.44% CSAN3 2.77 — 0.00% RAIZ4 24.40 ▼ 12.86% PCAR3 2.43 ▲ 1.25% GMAT3 3.83 ▲ 0.79% PSSA3 45.65 ▲ 2.93% CVCB3 0.87 ▲ 3.57% POSI3 3.03 ▼ 1.94% SLCE3 17.30 ▲ 4.15% NATU3 5.71 ▲ 10.44% BRKM5 3.02 ▼ 5.63% RANI3 8.76 ▲ 3.44% CSNA3 4.49 ▲ 1.81%
since 2009
Tuesday, November 10, 2026

Covid-19 Brazil

Covid-19: Johnson & Johnson applies for emergency use of vaccine from ANVISA

By · · 2 min read

RIO DE JANEIRO, BRAZIL – Brazil’s National Health Regulatory Agency (ANVISA) advised that it received, this Wednesday, 24th, the request for emergency use of the vaccine from Janssen, the pharmaceutical arm of Johnson & Johnson.

The regulator has already started the screening of the documents presented in the request.

The first 24 hours will be used to screen the file and verify that the necessary documents are available. If there is important information missing, ANVISA “may request the additional information from the laboratory.”

Free daily brief — no card needed
Get every Brazil story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.
1
ANVISA headquarters.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

To make its evaluation, ANVISA will use the information submitted along with the application and also the information already analyzed through continuous submission – which is the partial delivery of documents. The analysis of the emergency use request is done by a multidisciplinary team that involves specialists from the registration, monitoring, and inspection areas.

The agency’s goal, as described in a note, is to analyze the emergency use in up to seven working days, discounting any time that the process may be suspended pending information to be submitted by the laboratory.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Trump says deportations "might be too tough"”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

The Ministry of Health has purchased 38 million doses of the immunizer that provides protection against Covid-19 with a single dose. Deliveries are scheduled to occur from October to December 2021.

If approved, it will be the fourth immunizer to be authorized to reach the arms of Brazilians, along with the group formed by CoronaVac, AstraZeneca/Oxford, and Pfizer/BioNTech. The last two have full registration forgeneral use, not only emergency use.

Source: Veja

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.